X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2563) 2563
Publication (306) 306
Newsletter (44) 44
Book / eBook (27) 27
Book Review (27) 27
Book Chapter (17) 17
Newspaper Article (14) 14
Conference Proceeding (3) 3
Transcript (2) 2
Data Set (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2096) 2096
index medicus (1308) 1308
female (818) 818
animals (773) 773
male (721) 721
antigens (569) 569
middle aged (539) 539
immunology (537) 537
adult (503) 503
hematology (489) 489
mice (481) 481
rituximab (430) 430
cancer (413) 413
lymphocytes (412) 412
aged (411) 411
biochemistry & molecular biology (373) 373
medicine (371) 371
research (369) 369
flow cytometry (367) 367
cell biology (361) 361
immunohistochemistry (356) 356
research article (343) 343
oncology (340) 340
proteins (336) 336
b-lymphocytes - immunology (330) 330
immunotherapy (330) 330
pathology (323) 323
expression (316) 316
antigens, cd20 - immunology (312) 312
multidisciplinary sciences (297) 297
antibodies (295) 295
immunoglobulins (286) 286
science (271) 271
lymphomas (256) 256
cell line, tumor (252) 252
t cells (250) 250
b cells (245) 245
health aspects (239) 239
medicine, research & experimental (239) 239
therapy (237) 237
apoptosis (235) 235
lymphoma (233) 233
monoclonal antibodies (227) 227
antibodies, monoclonal - therapeutic use (220) 220
immune system (220) 220
lymphocytes b (218) 218
lymphocytes t (217) 217
tumors (215) 215
antigens, cd - analysis (213) 213
biochemistry (210) 210
immunophenotyping (207) 207
biology (200) 200
gene expression (200) 200
antigens, cd20 - analysis (194) 194
cytokines (191) 191
care and treatment (190) 190
analysis (189) 189
non-hodgkins-lymphoma (188) 188
antibodies, monoclonal, murine-derived (187) 187
hemic and lymphatic diseases (187) 187
leukemia (181) 181
antibodies, monoclonal - immunology (180) 180
cytotoxicity (178) 178
immune response (173) 173
monoclonal-antibody (172) 172
activation (170) 170
disease (170) 170
cd20 (169) 169
in-vivo (168) 168
chronic lymphocytic-leukemia (167) 167
article (166) 166
antigen (163) 163
medical research (163) 163
antigens, cd20 - metabolism (161) 161
t-cells (159) 159
monoclonal-antibodies (158) 158
physiological aspects (157) 157
aged, 80 and over (156) 156
adolescent (155) 155
b-lymphocytes - metabolism (152) 152
dendritic cells (150) 150
patients (150) 150
antibodies, monoclonal - pharmacology (147) 147
t-lymphocytes - immunology (146) 146
immune cells (145) 145
review (144) 144
abridged index medicus (143) 143
biology and life sciences (142) 142
t cell receptors (138) 138
genetic aspects (136) 136
immunity (136) 136
medicine and health sciences (135) 135
treatment outcome (134) 134
antibodies, monoclonal - chemistry (133) 133
cd20 antigen (131) 131
inflammation (130) 130
cells (129) 129
chemotherapy (128) 128
b-cell lymphoma (126) 126
molecular sequence data (126) 126
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (17) 17
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Trinity College (John W Graham) - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Online Resources - Online (1) 1
Scarborough Hospital - Hospital Department (1) 1
Toronto East General Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2634) 2634
Chinese (13) 13
French (8) 8
Russian (5) 5
Japanese (3) 3
Italian (2) 2
Spanish (2) 2
Hungarian (1) 1
Polish (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


中国药理学报:英文版, ISSN 1671-4083, 2018, Volume 39, Issue 2, pp. 261 - 274
Melanoma is the deadliest type of skin cancer. CD20+ melanoma stem cells (CSCs) are pivotal for metastasis and initiation of melanoma. Therefore, selective... 
类脂化合物;聚合物;干细胞;装载;压制;CSC;治疗学;细胞毒素 | CD20 | melanoma | salinomycin | nanoparticles | cancer stem cells | aptamers | DRUG-DELIVERY | MONOCLONAL-ANTIBODY | OPPORTUNITIES | CHEMISTRY, MULTIDISCIPLINARY | NANOMEDICINE STRATEGIES | TARGETED TREATMENT | IN-VITRO | LIVER-CANCER CELLS | THERAPY | LYMPHOMA | PHARMACOLOGY & PHARMACY | Lecithins - toxicity | Lecithins - metabolism | Drug Carriers - therapeutic use | Nanoparticles - chemistry | Neoplastic Stem Cells - drug effects | Humans | Drug Carriers - toxicity | Polyethylene Glycols - chemistry | Antineoplastic Agents - therapeutic use | Polyethylene Glycols - therapeutic use | Drug Carriers - chemistry | Lecithins - chemistry | Nanoparticles - therapeutic use | Nanoparticles - metabolism | Antineoplastic Agents - pharmacology | Pyrans - pharmacology | Pyrans - therapeutic use | Polyethylene Glycols - metabolism | Drug Carriers - metabolism | Aptamers, Nucleotide - toxicity | Lecithins - therapeutic use | Aptamers, Nucleotide - chemistry | Aptamers, Nucleotide - therapeutic use | Aptamers, Nucleotide - metabolism | Polyethylene Glycols - toxicity | Nanoparticles - toxicity | Particle Size | Xenograft Model Antitumor Assays | Animals | Melanoma - drug therapy | Mice, Inbred BALB C | Antigens, CD20 - chemistry | Drugs | Drug delivery systems | Effectiveness | Toxicity | Melanoma | Stem cell transplantation | Cytotoxicity | Lipids | Drug delivery | Skin cancer | Metastases | Nanoparticles | Salinomycin | Allografts | Cell lines | Stem cells | Aptamers | Xenografts | CD20 antigen | Skin | Conjugation | Polymers | Cancer | Original
Journal Article
Journal Article
mAbs, ISSN 1942-0862, 01/2013, Volume 5, Issue 1, pp. 22 - 33
Several novel anti-CD20 monoclonal antibodies are currently in development with the aim of improving the treatment of B cell malignancies. Mutagenesis and... 
leukemia | type II | ofatumumab | immunotherapy | Rituximab | non-Hodgkin lymphoma | type I | obinutuzumab | GA101 | structure | Non-Hodgkin lymphoma | Obinutuzumab | Immunotherapy | Leukemia | Type I | Type II | Ofatumumab | Structure | MEDICINE, RESEARCH & EXPERIMENTAL | MANTLE CELL LYMPHOMAS | FC-GAMMA-RIIIA | IBRITUMOMAB TIUXETAN RADIOIMMUNOTHERAPY | FOLLICULAR LYMPHOMA | RANDOMIZED CONTROLLED-TRIAL | REFRACTORY LOW-GRADE | NON-HODGKINS-LYMPHOMA | CHRONIC LYMPHOCYTIC-LEUKEMIA | TERM-FOLLOW-UP | ANTI-CD20 MAB | Epitope Mapping | Epitopes - metabolism | Humans | Molecular Sequence Data | Antibodies, Monoclonal - therapeutic use | Crystallography, X-Ray | Epitopes - immunology | Antibodies, Monoclonal - immunology | Amino Acid Sequence | Antigens, CD20 - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Antibodies, Monoclonal, Murine-Derived - immunology | Antibodies, Monoclonal, Humanized - metabolism | Antibodies, Monoclonal, Murine-Derived - metabolism | Models, Molecular | Clinical Trials as Topic | Antigens, CD20 - metabolism | Antigens, CD20 - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - therapy | Animals | Lymphoma, Non-Hodgkin - therapy | Epitopes - chemistry | Mice | Antibodies, Monoclonal - metabolism | Antibodies, Monoclonal, Humanized - immunology | Antigens, CD20 - chemistry | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Index Medicus | Review
Journal Article
Diabetes, ISSN 0012-1797, 11/2011, Volume 60, Issue 11, pp. 2914 - 2921
Journal Article
Analyst, ISSN 0003-2654, 10/2014, Volume 139, Issue 22, pp. 5660 - 5663
A novel dual-modal cell immunodetection method based on both dark-field imaging and catalysis functions of gold nanoparticles has been established, where the... 
GOLD NANOPARTICLES | CANCER-CELLS | CHEMISTRY, ANALYTICAL | Gold - chemistry | Molecular Probes | Cell Line | Humans | Antibodies, Monoclonal, Murine-Derived - chemistry | Rituximab | Antigens, CD20 - chemistry | Metal Nanoparticles | Nanoparticles | Gold | Conjugates | Imaging | Affinity | Labels | Nanostructure | Catalysis
Journal Article